134 related articles for article (PubMed ID: 9853689)
1. Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.
Kelly DL; Conley RR; Love RC; Horn DS; Ushchak CM
J Child Adolesc Psychopharmacol; 1998; 8(3):151-9. PubMed ID: 9853689
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
3. Risperidone-associated weight gain in children and adolescents: a retrospective chart review.
Martin A; Landau J; Leebens P; Ulizio K; Cicchetti D; Scahill L; Leckman JF
J Child Adolesc Psychopharmacol; 2000; 10(4):259-68. PubMed ID: 11191686
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
[TBL] [Abstract][Full Text] [Related]
5. Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study.
Gebhardt S; Theisen FM; Haberhausen M; Heinzel-Gutenbrunner M; Wehmeier PM; Krieg JC; Kühnau W; Schmidtke J; Remschmidt H; Hebebrand J
J Clin Pharm Ther; 2010 Apr; 35(2):207-11. PubMed ID: 20456740
[TBL] [Abstract][Full Text] [Related]
6. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
[TBL] [Abstract][Full Text] [Related]
7. Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.
Fleischhaker C; Heiser P; Hennighausen K; Herpertz-Dahlmann B; Holtkamp K; Mehler-Wex C; Rauh R; Remschmidt H; Schulz E; Warnke A
J Neural Transm (Vienna); 2007 Feb; 114(2):273-80. PubMed ID: 17109073
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic-induced weight gain: bipolar disorder and leptin.
McIntyre RS; Mancini DA; Basile VS; Srinivasan J; Kennedy SH
J Clin Psychopharmacol; 2003 Aug; 23(4):323-7. PubMed ID: 12920406
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.
Gross C; Blasey CM; Roe RL; Belanoff JK
Obesity (Silver Spring); 2010 Dec; 18(12):2295-300. PubMed ID: 20339369
[TBL] [Abstract][Full Text] [Related]
10. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of antipsychotics in prepubertal children: a retrospective chart review.
Ebert T; Midbari Y; Shmilovitz R; Kosov I; Kotler M; Weizman A; Ram A
J Child Adolesc Psychopharmacol; 2014 May; 24(4):218-22. PubMed ID: 24816004
[TBL] [Abstract][Full Text] [Related]
12. No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months.
Schoemakers RJ; van Kesteren C; van Rosmalen J; Eussen MLJM; Dieleman HG; Beex-Oosterhuis MM
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):192-196. PubMed ID: 30672720
[TBL] [Abstract][Full Text] [Related]
13. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting.
Pozzi M; Pisano S; Marano G; Carnovale C; Bravaccio C; Rafaniello C; Capuano A; Rossi F; Rizzo R; Bernardini R; Nobile M; Molteni M; Clementi E; Biganzoli E; Radice S
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):133-140. PubMed ID: 30452281
[TBL] [Abstract][Full Text] [Related]
14. Association between second-generation antipsychotics and changes in body mass index in adolescents.
Ghate SR; Porucznik CA; Said Q; Hashibe M; Joy E; Brixner DI
J Adolesc Health; 2013 Mar; 52(3):336-43. PubMed ID: 23427784
[TBL] [Abstract][Full Text] [Related]
15. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
16. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
Koga M
Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and safety profile of risperidone in a sample of children and adolescents.
Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
[TBL] [Abstract][Full Text] [Related]
18. Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.
Xiang YT; Wang CY; Ungvari GS; Kreyenbuhl JA; Chiu HF; Lai KY; Lee EH; Bo QJ; Dixon LB
Pharmacopsychiatry; 2011 Jun; 44(4):135-41. PubMed ID: 21710403
[TBL] [Abstract][Full Text] [Related]
19. Risperidone-associated steatohepatitis and excessive weight-gain.
Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
Arman S; Sadramely MR; Nadi M; Koleini N
Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
